Detection of phenolic metabolites of styrene in mouse liver and lung microsomal incubations.

Shuijie Shen,Fan Zhang,Lingbo Gao,Su Zeng,Jiang Zheng
DOI: https://doi.org/10.1124/dmd.110.033522
2010-01-01
Drug Metabolism and Disposition
Abstract:Metabolic activation is considered to be a critical step for styrene-induced pulmonary toxicity. Styrene-7,8-oxide is a primary oxidative metabolite generated by vinyl epoxidation of styrene. In addition, urinary 4-vinylphenol (4-VP), a phenolic metabolite formed by aromatic hydroxylation, has been detected in workers and experimental animals after exposure to styrene. In the present study, new oxidative metabolites of styrene, including 2-vinylphenol (2-VP), 3-vinylphenol (3-VP), vinyl-1,4-hydroquinone, and 2-hydroxystyrene glycol were detected in mouse liver microsomal incubations. The production rates of 2-VP, 3-VP, 4-VP, and styrene glycol were 0.0527 +/- 0.0045, 0.0019 +/- 0.0006, 0.0053 +/- 0.0002, and 4.42 +/- 0.33 nmol/(min . mg protein) in mouse liver microsomes, respectively. Both disulfiram (100 mu M) and 5-phenyl-1-pentyne (5 mu M) significantly inhibited the formation of the VPs and styrene glycol. 2-VP, 3-VP, and 4-VP were metabolized in mouse liver microsomes at rates of 2.50 +/- 0.30, 2.63 +/- 0.13, and 3.45 +/- 0.11 nmol/(min . mg protein), respectively. The three VPs were further metabolized to vinylcatechols and/or vinyl-1,4-hydroquinone and the corresponding glycols. Pulmonary toxicity of 2-VP, 3-VP, and 4-VP was evaluated in CD-1 mice, and 4-VP was found to be more toxic than 2-VP and 3-VP.
What problem does this paper attempt to address?